Jiangsu Nanfang Medical(SH:603880) Zhong Guo Ji Jin Bao·2025-08-08 01:44Core Viewpoint - The chairman and CFO of Nanwei Co., Ltd. have been penalized for insider trading, with fines totaling nearly 50 million yuan due to their illegal stock transactions during a sensitive period of undisclosed information [2][4]. Group 1: Insider Trading Penalties - Nanwei Co., Ltd. announced that its controlling shareholder and chairman, Li Ping, along with CFO Xiang Qinhua, were fined and had their illegal gains confiscated, amounting to approximately 50 million yuan [2][4]. - The China Securities Regulatory Commission (CSRC) found that Li Ping and Xiang Qinhua engaged in insider trading during the sensitive period from March 1 to April 28, 2023, after being aware of significant negative information regarding the company's financial status [4][5]. - Li Ping sold 8.184 million shares of Nanwei Co., Ltd. for 47.9678 million yuan between March 14 and March 28, 2023, resulting in a profit of 11.7767 million yuan after taxes [5]. Group 2: Financial Performance and Forecast - Nanwei Co., Ltd. is expected to report a net loss of 12 million to 16 million yuan for the first half of 2025, attributed to rising raw material costs and constraints on product orders due to international trade policies and geopolitical factors [6][9]. - The company primarily engages in the research, production, and sales of transdermal products, medical adhesive tapes, bandages, and emergency care products [7]. - As of the end of the first quarter, Li Ping held 119 million shares, representing a 41.12% ownership stake in the company [7].